Optimizing dosing schedules and administration routes is critical to maximize therapeutic efficacy while minimizing adverse effects such as hypoglycemia and gastrointestinal intolerance
For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate
Do you take other diabetes medicines, such as insulin or sulfonylureas
The $25 savings card never works uninsured
Wish to maintain a clearer, more even, and refreshed overall appearance
How Do Melanocortin Receptors Influence Melanotan 1 vs 2